EN
HI
Summary
As of 14 Sep, 2026, Mercury Laboratories stock price is ₹780. During the trading session, the stock has moved between an intraday low of ₹761.00 and an intraday high of ₹780.00. Over the last 52 weeks, Mercury Laboratories has traded between ₹620.55 and ₹942.90.
The stock has recorded a trading volume of 80 shares,. Its Average Traded Price (ATP) is ₹769.46, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹780.00.
Mercury Laboratories has an upper circuit limit of ₹936.00 and a lower circuit limit of ₹624.00. The total value traded stands at ₹61556.80, and the delivery percentage for the day is 68.75%.
The stock is currently traded with a market lot size of 1. Mercury Laboratories also offers a dividend yield of 0%.
Mercury Laboratories Share Price Chart
Mercury Laboratories Share Key Metrics
Volume
80.00
Market Cap
93.60 CR
LTQ@LTP
1@780.00
ATP
769.46
Var Margin
25 %
Circuit Range
624-936
Delivery %
68.75 %
Value
61556.80
ASM/GSM
No
Market Lot
1
Mercury Laboratories Resistance and Support
Pivot 773.67
Resistance
First Resistance
786.34
Second Resistance
792.67
Third Resistance
805.34
Support
First Support
767.34
Second Support
754.67
Third Support
748.34
Mercury Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 761 | 780 | -2.37% | 780 | 761 |
| Thu Sep 10 2026 | 760 | 798.9 | 4.99% | 799.79 | 760 |
| Wed Sep 09 2026 | 760 | 760.95 | 0.81% | 761 | 760 |
Mercury Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-25 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-14 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
Mercury Laboratories News
Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Mercury Laboratories will convene its 45th Annual General Meeting on September 28, 2026, via video conference. Key agenda includes the approval of a recommended final dividend of Rs. 3.5 per equity share for the financial year ended March 31, 2026, with September 21, 2026, fixed as the record date.
Aug 27 2026 12:29:01
Mercury Laboratories Ltd - 538964 - Communication To Shareholders - Intimation On Tax Deduction On Dividend
Mercury Laboratories recommended a Rs. 3.5 per equity share dividend for FY26, subject to AGM approval. Sep 21, 2026 is the record date. Shareholders are advised to update their PAN and other details for accurate Tax Deduction at Source (TDS) on dividend payments, as dividend income is now taxable in their hands.
Aug 20 2026 17:57:47
Mercury Laboratories Management
| Name | Position |
|---|---|
| Krishna Shah | Company Secretary & Compliance Officer |
| Rajendra R Shah | Managing Director |
Mercury Laboratories Similar Stocks
Lotus Eye Hospital And Institute Ltd.
113.25
0.00 (0.00%)
Lasa Supergenerics Ltd.
6.55
0.00 (0.00%)
Star Imaging and Path Lab Ltd.
79.49
0.00 (0.00%)
Alpa Laboratories Ltd.
61.75
-0.10 (0.16%)
Raaj Medisafe India Ltd.
99.85
0.00 (0.00%)
Makers Laboratories Ltd.
188.90
4.30 (2.33%)
Bharat Immunologicals & Biologicals Corporation Ltd.
15.11
0.00 (0.00%)
Pharmaids Pharmaceuticals Ltd.
30.39
0.08 (0.26%)
Concord Drugs Ltd.
79.68
0.01 (0.01%)
Mercury Laboratories FAQs
The Buying Price of Mercury Laboratories share is 780 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Mercury Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Mercury Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Mercury Laboratories shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Mercury Laboratories shares is 0. Useful to assess the stock's value relative to its book value.
To assess Mercury Laboratories’s valuation compare Sector P/E, P/B which are 41.67 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Mercury Laboratories is 93.60 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Mercury Laboratories share price is 942.90 & 620.55. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Mercury Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in MERCURYLAB
Or Download Choice FinX App
Invest in MERCURYLAB
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade